価格表

在庫・価格 : 2025年05月14日 19時43分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Programmed Death-1/Fc Chimera, Human, Recombinant, Carrier-free <PD-1>
データシート
1086-PD-050 RSDアールアンドディー システムズ
R&D Systems, Inc.
50 μg ¥91,000 1個 追加

在庫・価格 : 2025年05月14日 19時43分 現在

Programmed Death-1/Fc Chimera, Human, Recombinant, Carrier-free <PD-1>

  • 商品コード:1086-PD-050
  • メーカー:RSD
  • 包装:50μg
  • 価格: ¥91,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Gonzalez LC et al. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. U.S.A. 2005 Jan;102(4):1116-21
Gonzalez LC et al
2005/01/01
Species: Human, Application: Binding Assay, Sample type: recombinant B7-H1 PubMed
2 Wan B et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 2006 Dec;177(12):8844-50
Wan B et al
2006/01/01
Application: Bioassay,ELISA Standard, Sample Type: Serum,Synovial Fluid,Whole Cells PubMed
3 Sakthivel P et al. Programmed Death-1: from gene to protein in autoimmune human myasthenia gravis. J. Neuroimmunol. 2008 Jan;193(1-2):149-55
Sakthivel P et al
2008/01/01
Application: ELISA Standard PubMed
4 Kim YS et al. Cross-linking of B7-H1 on EBV-transformed B cells induces apoptosis through reactive oxygen species production, JNK signaling activation, and fasL expression. J. Immunol. 2008 Nov;181(9):6158-69
Kim YS et al
2008/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
5 Steidl C et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011 Mar;471(7338):377-81
Steidl C et al
2011/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Melendreras SG et al. Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients. PLoS ONE 2014;9(12):e113396
Melendreras SG et al
2014/01/01
Application: ELISA Standard, Sample Type: Serum PubMed
7 Yang Y et al. B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor. Oncol Lett 2015 Apr;9(4):1833-1838
Yang Y et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Brahmer JR et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 2010 Jul;28(19):3167-75
Brahmer JR et al
2010/01/01
Application: ELISA capture, Sample Type: Serum PubMed
9 Kataoka K et al. Aberrant PD-L1 expression through 3&#39;-UTR disruption in multiple cancers. Nature 2016 06;534(7607):402-6
Kataoka K et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
10 Li CW et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun 2016 Aug;7:12632
Li CW et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Gonzalez LC et al. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc. Natl. Acad. Sci. U.S.A. 2005 Jan;102(4):1116-21
    Gonzalez LC et al
    2005/01/01
  • 備考:
    Species: Human, Application: Binding Assay, Sample type: recombinant B7-H1
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Wan B et al. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 2006 Dec;177(12):8844-50
    Wan B et al
    2006/01/01
  • 備考:
    Application: Bioassay,ELISA Standard, Sample Type: Serum,Synovial Fluid,Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Sakthivel P et al. Programmed Death-1: from gene to protein in autoimmune human myasthenia gravis. J. Neuroimmunol. 2008 Jan;193(1-2):149-55
    Sakthivel P et al
    2008/01/01
  • 備考:
    Application: ELISA Standard
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kim YS et al. Cross-linking of B7-H1 on EBV-transformed B cells induces apoptosis through reactive oxygen species production, JNK signaling activation, and fasL expression. J. Immunol. 2008 Nov;181(9):6158-69
    Kim YS et al
    2008/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Steidl C et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 2011 Mar;471(7338):377-81
    Steidl C et al
    2011/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Melendreras SG et al. Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients. PLoS ONE 2014;9(12):e113396
    Melendreras SG et al
    2014/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Yang Y et al. B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor. Oncol Lett 2015 Apr;9(4):1833-1838
    Yang Y et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Brahmer JR et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 2010 Jul;28(19):3167-75
    Brahmer JR et al
    2010/01/01
  • 備考:
    Application: ELISA capture, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Kataoka K et al. Aberrant PD-L1 expression through 3&#39;-UTR disruption in multiple cancers. Nature 2016 06;534(7607):402-6
    Kataoka K et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Li CW et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun 2016 Aug;7:12632
    Li CW et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed